---
title: "PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort"
collection: publications
category: manuscripts
permalink: /publications/2024-wang-pcca-ejc
excerpt: "European Journal of Cancer, 213, 115114."
date: 2024-01-01
venue: 'European Journal of Cancer'
authors: 'Wang, Y., Xiong, C., Yu, W., Zhou, M., Shugg, T. A., Hsu, F. C., Eadon, M. T., Su, J., & Song, Q.'
citation: 'Wang, Y., Xiong, C., Yu, W., Zhou, M., Shugg, T. A., Hsu, F. C., Eadon, M. T., Su, J., & Song, Q. (2024). PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment. <i>European Journal of Cancer</i>, 213, 115114. doi:10.1016/j.ejca.2024.115114'
---

Wang, Y., Xiong, C., Yu, W., Zhou, M., Shugg, T. A., Hsu, F. C., Eadon, M. T., Su, J., & Song, Q. (2024). PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort. *European Journal of Cancer*, 213, 115114. doi:10.1016/j.ejca.2024.115114
